參考文獻

oral submucous fibrosis, verrucous hyperplasia and squamous cell carcinoma
tissues. Kaohsiung J Med Sci 15(9):513-9., 1999
14. Bo T, Jonassen I. New feature subset selection procedures for classification of
expression profiles. Genome Biol 3(4), 2002
15. Pindborg JJ, Sirsat SM. Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol
22(6):764-79., 1966
16. Wahi PN, Luthra UK, Kapur VL. Submucous fibrosis of the oral cavity.
Histomorphological studies. Br J Cancer 20(4):676-87., 1966
17. Schiwartz J. Atrophica idiopathia tropica mucosae oris. Demaostrated at the 11th
international dental congress,Lodon 1952.
18. Lal D. Diffuse oral submucous fibrosis. J. All-India Dent Assoc 26:1-3, 1953
19. Tai YS, Liu BY, Wang JT, Sun A, Kwan HW, Chiang CP. Oral administration of
milk from cows immunized with human intestinal bacteria leads to significant
improvements of symptoms and signs in patients with oral submucous fibrosis. J
Oral Pathol Med 30(10):618-25., 2001
20. Ramanathan K. Oral submucous fibrosis--an alternative hypothesis as to its
causes. Med J Malaysia 36(4):243-5., 1981
21. Paul RR, Chatterjee J, Das AK, Dutta SK, Roy D. Zinc and iron as bioindicators
of precancerous nature of oral submucous fibrosis. Biol Trace Elem Res
54(3):213-30., 1996
22. Shiau YY, Kwan HW. Submucous fibrosis in Taiwan. Oral Surg Oral Med Oral
Pathol 47(5):453-7., 1979
23. Sen S, Talukder G, Sharma A. Betel cytotoxicity. J Ethnopharmacol 26(3):217-47.,
1989
24. Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Pindborg JJ, Mehta FS. Etiology
of oral submucous fibrosis with special reference to the role of areca nut chewing.
J Oral Pathol Med 24(4):145-52., 1995
25. Pindborg JJ, Zheng KH, Kong CR, Lin FX. Pilot survey of oral mucosa in areca
(betel) nut chewers on Hainan Island of the People's Republic of China.
Community Dent Oral Epidemiol 12(3):195-6., 1984
26. Hashibe M, Sankaranarayanan R, Thomas G, et al.: Body mass index, tobacco
chewing, alcohol drinking and the risk of oral submucous fibrosis in Kerala, India.
Cancer Causes Control 13(1):55-64., 2002
27. Balaram P, Pillai MR, Abraham T. Immunology of premalignant and malignant
conditions of the oral cavity. II. Circulating immune complexes. J Oral Pathol
16(8):389-91., 1987
28. Shah N, Kumar R, Shah MK. Immunological studies in oral submucous fibrosis.
Indian J Dent Res 5(3):81-7., 1994
44

oral precancer and cancer. J Dent Assoc S Afr Suppl 1:18-20., 1989
46. Pindborg JJ, Zachariah J. Frequency of oral submucous fibrosis among 100 South
Indians with oral cancer. Bull World Health Organ 32(5):750-3, 1965
47. Seedat HA, van Wyk CW. Betel chewing and dietary habits of chewers without
and with submucous fibrosis and with concomitant oral cancer. S Afr Med J
74(11):572-5., 1988
48. Maher R, Lee AJ, Warnakulasuriya KA, Lewis JA, Johnson NW. Role of areca nut
in the causation of oral submucous fibrosis: a case- control study in Pakistan. J
Oral Pathol Med 23(2):65-9., 1994
49. Babu S, Sesikeran B, Bhat RV. Oral fibrosis among teenagers chewing tobacco,
areca nut, and Pan masala. Lancet 348(9028):692., 1996
50. Harvey W, Scutt A, Meghji S, Canniff JP. Stimulation of human buccal mucosa
fibroblasts in vitro by betel-nut alkaloids. Arch Oral Biol 31(1):45-9, 1986
51. Jeng JH, Tsai CL, Hahn LJ, Yang PJ, Kuo YS, Kuo MY. Arecoline cytotoxicity on
human oral mucosal fibroblasts related to cellular thiol and esterase activities.
Food Chem Toxicol 37(7):751-6., 1999
52. Tsai CC, Ma RH, Shieh TY. Deficiency in collagen and fibronectin phagocytosis
by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral
submucous fibrosis. J Oral Pathol Med 28(2):59-63., 1999
53. Sirsat SM, Pindborg JJ. Subepithelial changes in oral submucous fibrosis. Acta
Pathol Microbiol Scand 70(2):161-73, 1967
54. el-Labban NG, Canniff JP. Ultrastructural findings of muscle degeneration in oral
submucous fibrosis. J Oral Pathol 14(9):709-17., 1985
55. Chiang CP, Lang MJ, Liu BY, et al.: Expression of p53 protein in oral submucous
fibrosis, oral epithelial hyperkeratosis, and oral epithelial dysplasia. J Formos Med
Assoc 99(3):229-34., 2000
56. Meghji S, Scutt A, Harvey W, Canniff JP. An in-vitro comparison of human
fibroblasts from normal and oral submucous fibrosis tissue. Arch Oral Biol
32(3):213-5, 1987
57. de Waal J, Olivier A, van Wyk CW, Maritz JS. The fibroblast population in oral
submucous fibrosis. J Oral Pathol Med 26(2):69-74., 1997
58. Kuo MY, Chen HM, Hahn LJ, Hsieh CC, Chiang CP. Collagen biosynthesis in
human oral submucous fibrosis fibroblast cultures. J Dent Res 74(11):1783-8.,
1995
59. Canniff JP, Harvey W. The aetiology of oral submucous fibrosis: the stimulation
of collagen synthesis by extracts of areca nut. Int J Oral Surg 10(Suppl):163-7.,
1981
60. Scutt A, Meghji S, Canniff JP, Harvey W. Stabilisation of collagen by betel nut
46

polyphenols as a mechanism in oral submucous fibrosis. Experientia 43(4):391-3.,
1987
61. Haque MF, Harris M, Meghji S, Barrett AW. Immunolocalization of cytokines and
growth factors in oral submucous fibrosis. Cytokine 10(9):713-9., 1998
62. Chang YC, Yang SF, Tai KW, Chou MY, Hsieh YS. Increased tissue inhibitor of
metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal
mucosal fibroblasts by arecoline as possible mechanisms for oral submucous
fibrosis. Oral Oncol 38(2):195-200., 2002
63. Chang MC, Ho YS, Lee PH, et al.: Areca nut extract and arecoline induced the
cell cycle arrest but not apoptosis of cultured oral KB epithelial cells: association
of glutathione, reactive oxygen species and mitochondrial membrane potential.
Carcinogenesis 22(9):1527-35., 2001
64. Ma RH, Tsai CC, Shieh TY. Increased lysyl oxidase activity in fibroblasts
cultured from oral submucous fibrosis associated with betel nut chewing in
Taiwan. J Oral Pathol Med 24(9):407-12., 1995
65. Chen CC, Huang JF, Tsai CC. In vitro production of interleukin-6 by human
gingival, normal buccal mucosa, and oral submucous fibrosis fibroblasts treated
with betel-nut alkaloids. Gaoxiong Yi Xue Ke Xue Za Zhi 11(11):604-14., 1995
66. Ghosh PK, Madhavi R, Guntur M, Ghosh R. Sister chromatid exchanges in
patients with oral submucous fibrosis. Cancer Genet Cytogenet 44(2):197-201.,
1990
67. Chiu CJ, Chiang CP, Chang ML, et al.: Association between genetic
polymorphism of tumor necrosis factor-alpha and risk of oral submucous fibrosis,
a pre-cancerous condition of oral cancer. J Dent Res 80(12):2055-9., 2001
68. Wang HM, Wang CH, Chen JS, Su CL, Liao CT, Chen IH. Impact of oral
submucous fibrosis on chemotherapy-induced mucositis for head and neck cancer
in a geographic area in which betel quid chewing is prevalent. Am J Clin Oncol
22(5):485-8., 1999
69. Zhu H, Snyder M. Protein arrays and microarrays. Curr Opin Chem Biol
5(1):40-5., 2001
70. Paweletz CP, Charboneau L, Bichsel VE, et al.: Reverse phase protein
microarrays which capture disease progression show activation of pro-survival
pathways at the cancer invasion front. Oncogene 20(16):1981-9., 2001
71. Luo LY, Diamandis EP. Preliminary examination of time-resolved fluorometry for
protein array applications. Luminescence 15(6):409-13., 2000
72. Benoit V, Steel A, Torres M, Yu YY, Yang H, Cooper J. Evaluation of
three-dimensional microchannel glass biochips for multiplexed nucleic acid
fluorescence hybridization assays. Anal Chem 73(11):2412-20., 2001
47

73. Burgess JK, Hazelton RH. New developments in the analysis of gene expression.
Redox Rep 5(2-3):63-73, 2000
74. Cheung VG, Morley M, Aguilar F, Massimi A, Kucherlapati R, Childs G. Making
and reading microarrays. Nat Genet 21(1 Suppl):15-9., 1999
75. Chang YC, Hu CC, Tseng TH, Tai KW, Lii CK, Chou MY. Synergistic effects of
nicotine on arecoline-induced cytotoxicity in human buccal mucosal fibroblasts. J
Oral Pathol Med 30(8):458-64., 2001
76. Park IK, He Y, Lin F, et al.: Differential gene expression profiling of adult murine
hematopoietic stem cells. Blood 99(2):488-98., 2002
77. Ramsay G. DNA chips: state-of-the art. Nat Biotechnol 16(1):40-4., 1998
78. Southern E. Gel electrophoresis of restriction fragments. Methods Enzymol
68:152-76, 1979
79. Maskos U, Southern EM. Oligonucleotide hybridizations on glass supports: a
novel linker for oligonucleotide synthesis and hybridization properties of
oligonucleotides synthesised in situ. Nucleic Acids Res 20(7):1679-84., 1992
80. Southern EM, Case-Green SC, Elder JK, et al.: Arrays of complementary
oligonucleotides for analysing the hybridisation behaviour of nucleic acids.
Nucleic Acids Res 22(8):1368-73., 1994
81. Williams JC, Case-Green SC, Mir KU, Southern EM. Studies of oligonucleotide
interactions by hybridisation to arrays: the influence of dangling ends on duplex
yield. Nucleic Acids Res 22(8):1365-7., 1994
82. Chiang CP, Wu HY, Liu BY, Wang JT, Kuo MY. Quantitative analysis of
immunocompetent cells in oral submucous fibrosis in Taiwan. Oral Oncol
38(1):56-63., 2002
83. Chee M, Yang R, Hubbell E, et al.: Accessing genetic information with
high-density DNA arrays. Science 274(5287):610-4., 1996
84. Kallioniemi OP. Biochip technologies in cancer research. Ann Med 33(2):142-7.,
2001
85. Carulli JP, Artinger M, Swain PM, et al.: High throughput analysis of differential
gene expression. J Cell Biochem Suppl 31:286-96, 1998
86. Aharoni A, Vorst O. DNA microarrays for functional plant genomics. Plant Mol
Biol 48(1-2):99-118., 2002
87. Adorjan P, Distler J, Lipscher E, et al.: Tumour class prediction and discovery by
microarray-based DNA methylation analysis. Nucleic Acids Res 30(5):e21., 2002
88. Amundson SA, Fornace AJ, Jr.: Gene expression profiles for monitoring radiation
exposure. Radiat Prot Dosimetry 97(1):11-6, 2001
89. Bull JH, Ellison G, Patel A, et al.: Identification of potential diagnostic markers of
prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray. Br
48

J Cancer 84(11):1512-9., 2001
90. Haviv I, Campbell IG. DNA microarrays for assessing ovarian cancer gene
expression. Mol Cell Endocrinol 191(1):121-6., 2002
91. Hedenfalk I, Duggan D, Chen Y, et al.: Gene-expression profiles in hereditary
breast cancer. N Engl J Med 344(8):539-48., 2001
92. Howell SB. DNA Microarrays for Analysis of Gene Expression. Mol Urol
3(3):295-300, 1999
93. Aronow BJ, Richardson BD, Handwerger S. Microarray analysis of trophoblast
differentiation: gene expression reprogramming in key gene function categories.
Physiol Genomics 6(2):105-16., 2001
94. Bednar M. DNA microarray technology and application. Med Sci Monit
6(4):796-800., 2000
95. Burke HB. Discovering patterns in microarray data. Mol Diagn 5(4):349-57.,
2000
96. Brown V, Jin P, Ceman S, et al.: Microarray identification of FMRP-associated
brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell
107(4):477-87., 2001
97. Aguilar J, Roy D, Ghazal P, Wagner E. Dimethyl sulfoxide blocks herpes simplex
virus-1 productive infection in vitro acting at different stages with positive
cooperativity. Application of micro-array analysis. BMC Infect Dis 2(1):9., 2002
98. Chizhikov V, Rasooly A, Chumakov K, Levy DD. Microarray analysis of
microbial virulence factors. Appl Environ Microbiol 67(7):3258-63., 2001
99. Geiss GK, Bumgarner RE, An MC, et al.: Large-scale monitoring of host cell
gene expression during HIV-1 infection using cDNA microarrays. Virology
266(1):8-16., 2000
100. Honda M, Kaneko S, Kawai H, Shirota Y, Kobayashi K. Differential gene
expression between chronic hepatitis B and C hepatic lesion. Gastroenterology
120(4):955-66., 2001
101. Hwang D, Alevizos I, Schmitt WA, et al.: Genomic dissection for
characterization of cancerous oral epithelium tissues using transcription profiling.
Oral Oncol 39(3):259-68, 2003
102. Leethanakul C, Knezevic V, Patel V, et al.: Gene discovery in oral squamous cell
carcinoma through the Head and Neck Cancer Genome Anatomy Project:
confirmation by microarray analysis. Oral Oncol 39(3):248-58, 2003
103. Ruutu M, Peitsaro P, Johansson B, Syrjanen S. Transcriptional profiling of a
human papillomavirus 33-positive squamous epithelial cell line which acquired a
selective growth advantage after viral integration. Int J Cancer 100(3):318-26,
2002
49

104. Alevizos I, Mahadevappa M, Zhang X, et al.: Oral cancer in vivo gene
expression profiling assisted by laser capture microdissection and microarray
analysis. Oncogene 20(43):6196-204., 2001
105. Heikinheimo K, Jee KJ, Niini T, et al.: Gene expression profiling of
ameloblastoma and human tooth germ by means of a cDNA microarray. J Dent
Res 81(8):525-30, 2002
106. Kessler D, Dethlefsen S, Haase I, et al.: Fibroblasts in mechanically stressed
collagen lattices assume a "synthetic" phenotype. J Biol Chem 276(39):36575-85.,
2001
107. Moussad EE, Brigstock DR. Connective tissue growth factor: what's in a name?
Mol Genet Metab 71(1-2):276-92., 2000
108. Collet C, Candy J. How many insulin-like growth factor binding proteins? Mol
Cell Endocrinol 139(1-2):1-6., 1998
109. MacLeish MY, Moreno NP, Tharp BZ, Denton JJ, Jessup G, Clipper MC.
Improving science literacy and education through space life sciences. Acta
Astronaut 49(3-10):469-76., 2001
110. Ito Y, Aten J, Bende RJ, et al.: Expression of connective tissue growth factor in
human renal fibrosis. Kidney Int 53(4):853-61., 1998
111. Matsuyama A, Inoue H, Shibuta K, et al.: Hepatoma-derived growth factor is
associated with reduced sensitivity to irradiation in esophageal cancer. Cancer Res
61(15):5714-7., 2001
112. Adhvaryu SG, Dave BJ, Trivedi AH. Cytogenetic surveillance of tobacco-areca
nut (mava) chewers, including patients with oral cancers and premalignant
conditions. Mutat Res 261(1):41-9., 1991
113. Son HJ, Rhee JC, Park DI, et al.: Inducible nitric oxide synthase expression in
gastroduodenal diseases infected with Helicobacter pylori. Helicobacter
6(1):37-43., 2001
114. Voravud N, Charuruks N, Mutirangura A. Squamous cell carcinoma of head and
neck. J Med Assoc Thai 80(4):207-18, 1997
115. Yudate T, Isaka K, Suzuki Y, et al.: [mRNA expression and protein localization
of placental tissue protein 11, 12, 19 in gynecologic malignant tumors]. Nippon
Sanka Fujinka Gakkai Zasshi 47(11):1248-54., 1995
116. Deal C, Ma J, Wilkin F, et al.: Novel promoter polymorphism in insulin-like
growth factor-binding protein-3: correlation with serum levels and interaction
with known regulators. J Clin Endocrinol Metab 86(3):1274-80., 2001
117. Furstenberger G, Senn HJ. Insulin-like growth factors and cancer. Lancet Oncol
3(5):298-302., 2002
118. Monti S, Di Silverio F, Lanzara S, et al.: Insulin-like growth factor-I and -II in
50

human benign prostatic hyperplasia: relationship with binding proteins 2 and 3
and androgens. Steroids 63(5-6):362-6., 1998
119. Leethanakul C, Patel V, Gillespie J, et al.: Gene expression profiles in squamous
cell carcinomas of the oral cavity: use of laser capture microdissection for the
construction and analysis of stage-specific cDNA libraries. Oral Oncol
36(5):474-83., 2000
120. Lin SC, Wang CP, Chen YM, et al.: Regulation of IGFBP-5 expression during
tumourigenesis and differentiation of oral keratinocytes. J Pathol 198(3):317-25.,
2002
121. Cwikla SJ, Tsuji T, McBride J, Wong DT, Todd R. doc-1--mediated apoptosis in
malignant hamster oral keratinocytes. J Oral Maxillofac Surg 58(4):406-14., 2000
122. Chang HW, Chow V, Lam KY, Wei WI, Yuen A. Loss of E-cadherin expression
resulting from promoter hypermethylation in oral tongue carcinoma and its
prognostic significance. Cancer 94(2):386-92., 2002
123. Downer CS, Speight PM. E-cadherin expression in normal, hyperplastic and
malignant oral epithelium. Eur J Cancer B Oral Oncol 29B(4):303-5., 1993
124. Farmer I, Freysdottir J, Dalghous AM, Fortune F. Expression of adhesion and
activation molecules in human buccal epithelial cell lines and normal human
buccal epithelium in situ. J Oral Pathol Med 30(2):113-20., 2001
125. Kellen JA, Mirakian A. The effect of toremifene on the expression of genes in a
rat mammary adenocarcinoma. In Vivo 10(5):511-3., 1996
126. Xia L, Stoll SW, Liebert M, et al.: CaN19 expression in benign and malignant
hyperplasias of the skin and oral mucosa: evidence for a role in regenerative
differentiation. Cancer Res 57(14):3055-62., 1997
127. Elahi A, Zheng Z, Park J, Eyring K, McCaffrey T, Lazarus P. The human OGG1
DNA repair enzyme and its association with orolaryngeal cancer risk.
Carcinogenesis 23(7):1229-34., 2002
128. Parlanti E, Fortini P, Macpherson P, Laval J, Dogliotti E. Base excision repair of
adenine/8-oxoguanine mispairs by an aphidicolin- sensitive DNA polymerase in
human cell extracts. Oncogene 21(34):5204-12., 2002
129. Janssen K, Schlink K, Gotte W, Hippler B, Kaina B, Oesch F. DNA repair
activity of 8-oxoguanine DNA glycosylase 1 (OGG1) in human lymphocytes is
not dependent on genetic polymorphism Ser326/Cys326. Mutat Res
486(3):207-16., 2001
130. Chen CL, Chi CW, Liu TY. Hydroxyl radical formation and oxidative DNA
damage induced by areca quid in vivo. J Toxicol Environ Health A
65(3-4):327-36., 2002
131. Asami S, Manabe H, Miyake J, et al.: Cigarette smoking induces an increase in
51

oxidative DNA damage, 8- hydroxydeoxyguanosine, in a central site of the human
lung. Carcinogenesis 18(9):1763-6., 1997
132. Cahill A, Wang X, Hoek JB. Increased oxidative damage to mitochondrial DNA
following chronic ethanol consumption. Biochem Biophys Res Commun
235(2):286-90., 1997
133. Choi J, Yoon SH, Kim JE, Rhee KH, Youn HS, Chung MH. Gene-specific
oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Int
J Cancer 99(4):485-90., 2002
134. Jayanthi V, Probert CS, Sher KS, Mayberry JF. Oral submucosal fibrosis--a
preventable disease. Gut 33(1):4-6., 1992
135. Seedat HA, van Wyk CW. Submucous fibrosis in non-betel nut chewing subjects.
J Biol Buccale 16(1):3-6., 1988
136. Pindborg JJ. Epidemiology and public health aspects of diseases of the oral
mucosa. J Dent Res 56 Spec No:C14-9., 1977
137. Shah N, Sharma PP. Role of chewing and smoking habits in the etiology of oral
submucous fibrosis (OSF): a case-control study. J Oral Pathol Med 27(10):475-9.,
1998
138. Norton SA. Betel: consumption and consequences. J Am Acad Dermatol
38(1):81-8., 1998
139. Adhvaryu SG, Bhatt RG, Dayal PK, et al.: SCE frequencies in lymphocytes of
tobacco/betel nut chewers and patients with oral submucous fibrosis. Br J Cancer
53(1):141-3., 1986
140. Desai SS, Ghaisas SD, Jakhi SD, Bhide SV. Cytogenetic damage in exfoliated
oral mucosal cells and circulating lymphocytes of patients suffering from
precancerous oral lesions. Cancer Lett 109(1-2):9-14., 1996
141. Basu S, Srivastava PK. Calreticulin, a peptide-binding chaperone of the
endoplasmic reticulum, elicits tumor- and peptide-specific immunity. J Exp Med
189(5):797-802., 1999
142. Luo X, Weber GA, Zheng J, Gendelman HE, Ikezu T. C1q-calreticulin induced
oxidative neurotoxicity: relevance for the neuropathogenesis of Alzheimer's
disease. J Neuroimmunol 135(1-2):62-71, 2003
143. Pike SE, Yao L, Setsuda J, et al.: Calreticulin and calreticulin fragments are
endothelial cell inhibitors that suppress tumor growth. Blood 94(7):2461-8., 1999
144. Zhu Q, Zelinka P, White T, Tanzer ML. Calreticulin-integrin bidirectional
signaling complex. Biochem Biophys Res Commun 232(2):354-8., 1997
145. Bogumil R, Namgaladze D, Schaarschmidt D, et al.: Inactivation of calcineurin
by hydrogen peroxide and phenylarsine oxide. Evidence for a dithiol-disulfide
equilibrium and implications for redox regulation. Eur J Biochem 267(5):1407-15,
52

2000
146. Pardo JM, Reddy MP, Yang S, et al.: Stress signaling through
Ca2+/calmodulin-dependent protein phosphatase calcineurin mediates salt
adaptation in plants. Proc Natl Acad Sci U S A 95(16):9681-6, 1998
147. Jung Y, Surh Y. Oxidative DNA damage and cytotoxicity induced by
copper-stimulated redox cycling of salsolinol, a neurotoxic tetrahydroisoquinoline
alkaloid. Free Radic Biol Med 30(12):1407-17, 2001
148. Reiter RJ, Acuna-Castroviejo D, Tan DX, Burkhardt S. Free radical-mediated
molecular damage. Mechanisms for the protective actions of melatonin in the
central nervous system. Ann N Y Acad Sci 939:200-15, 2001
149. Hawk SN, Lanoue L, Keen CL, Kwik-Uribe CL, Rucker RB, Uriu-Adams JY.
Copper-deficient rat embryos are characterized by low superoxide dismutase
activity and elevated superoxide anions. Biol Reprod 68(3):896-903, 2003
150. Chern CL, Huang RF, Chen YH, Cheng JT, Liu TZ. Folate deficiency-induced
oxidative stress and apoptosis are mediated via homocysteine-dependent
overproduction of hydrogen peroxide and enhanced activation of NF-kappaB in
human Hep G2 cells. Biomed Pharmacother 55(8):434-42, 2001
151. Sauri H, Butterfield L, Kim A, Shau H. Antioxidant function of recombinant
human natural killer enhancing factor. Biochem Biophys Res Commun
208(3):964-9, 1995
152. Balcer-Kubiczek EK, Zhang XF, Han LH, et al.: BIGEL analysis of gene
expression in HL60 cells exposed to X rays or 60 Hz magnetic fields. Radiat Res
150(6):663-72, 1998
153. Gao S, Liu S, Shen Z, Peng L. Morphometric analysis of spinous cell in oral
submucous fibrosis. Comparison with normal mucosa, leukoplakia and squamous
cell carcinoma. Chin Med J (Engl) 108(5):351-4., 1995
154. Nachtigal M, Al-Assaad Z, Mayer EP, Kim K, Monsigny M. Galectin-3
expression in human atherosclerotic lesions. Am J Pathol 152(5):1199-208., 1998
155. Yamaoka A, Kuwabara I, Frigeri LG, Liu FT. A human lectin, galectin-3 (epsilon
bp/Mac-2), stimulates superoxide production by neutrophils. J Immunol
154(7):3479-87., 1995
156. Liu FT, Hsu DK, Zuberi RI, et al.: Modulation of functional properties of
galectin-3 by monoclonal antibodies binding to the non-lectin domains.
Biochemistry 35(19):6073-9., 1996
157. Varghese I, Sugathan CK, Balasubramoniyan G, Vijayakumar T. Serum copper
and zinc levels in premalignant and malignant lesions of the oral cavity. Oncology
44(4):224-7, 1987
158. Botvin'eva VV, Mikheeva GA. [Condition of nonspecific immunological
53

eactivity in post-tuberculous and post-pneumonia pneumosclerosis in children
during the first years of life]. Probl Tuberk 47(5):26-30, 1969
159. Kasper M, Lackie P, Haase M, Schuh D, Muller M. Immunolocalization of
cathepsin D in pneumocytes of normal human lung and in pulmonary fibrosis.
Virchows Arch 428(4-5):207-15., 1996
160. Stypmann J, Glaser K, Roth W, et al.: Dilated cardiomyopathy in mice deficient
for the lysosomal cysteine peptidase cathepsin L. Proc Natl Acad Sci U S A
99(9):6234-9., 2002
161. Tsujii T, Fukuhara M, Fukuda S, Matsui T, Matsuoka Y. Studies on the inhibition
of experimental liver fibrosis. 2. The mechanism of the inhibition of liver fibrosis
of rats due to carbon tetrachloride by elastase. Gastroenterol Jpn 10(3):215-20,
1975
162. Sotaniemi EA, Niemela O, Risteli L, et al.: Fibrotic process and drug
metabolism in alcoholic liver disease. Clin Pharmacol Ther 40(1):46-55., 1986
163. Marshall FH, White J, Main M, Green A, Wise A. GABA(B) receptors function as
heterodimers. Biochem Soc Trans 27(4):530-5., 1999
164. Uezono Y, Ueda Y, Ueno S, et al.: Enhancement by baclofen of the Gs-coupled
receptor-mediated cAMP production in Xenopus oocytes expressing rat brain
cortex poly (A)+ RNA: a role of G-protein beta gamma subunits. Biochem
Biophys Res Commun 241(2):476-80., 1997
165. Dodd PR, Kril JJ, Thomas GJ, Watson WE, Johnston GA, Harper CG. Receptor
binding sites and uptake activities mediating GABA neurotransmission in chronic
alcoholics with Wernicke encephalopathy. Brain Res 710(1-2):215-28., 1996
166. Demol P, Ruoff HJ, Weihrauch TR. Rational pharmacotherapy of
gastrointestinal motility disorders. Eur J Pediatr 148(6):489-95., 1989
167. Lonardo A, Loria P. Of liver, whisky and plants: a requiem for colchicine in
alcoholic cirrhosis? Eur J Gastroenterol Hepatol 14(4):355-8., 2002
168. Desai VC, Naziruddin B, Graves DC, Reyes de la Rocha S, Sachdev GP.
Production and characterization of monoclonal antibodies to purified
deglycosylated cystic fibrosis respiratory mucin: evidence for the presence of four
immunologically distinct epitopes. Hybridoma 10(2):285-96., 1991
169. Bebok Z, Mazzochi C, King SA, Hong JS, Sorscher EJ. The mechanism
underlying cystic fibrosis transmembrane conductance regulator transport from
the endoplasmic reticulum to the proteasome includes Sec61beta and a cytosolic,
deglycosylated intermediary. J Biol Chem 273(45):29873-8., 1998
170. Seibert FS, Loo TW, Clarke DM, Riordan JR. Cystic fibrosis: channel, catalytic,
and folding properties of the CFTR protein. J Bioenerg Biomembr 29(5):429-42.,
1997
54

171. Smits JF, Passier RC, Nelissen-Vrancken HJ, Cleutjens JP, Kuizinga MC,
Daemen MJ. Does ACE inhibition limit structural changes in the heart following
myocardial infarction? Eur Heart J 16 Suppl N:46-51., 1995
172. Gilbert A, Jadot M, Leontieva E, Wattiaux-De Coninck S, Wattiaux R. Delta
F508 CFTR localizes in the endoplasmic reticulum-Golgi intermediate
compartment in cystic fibrosis cells. Exp Cell Res 242(1):144-52., 1998
173. Agarwal DP. Molecular genetic aspects of alcohol metabolism and alcoholism.
Pharmacopsychiatry 30(3):79-84., 1997
174. Matsumoto M, Takahashi H, Maruyama K, et al.: Genotypes of
alcohol-metabolizing enzymes and the risk for alcoholic chronic pancreatitis in
Japanese alcoholics. Alcohol Clin Exp Res 20(9 Suppl):289A-292A., 1996
175. Ohhira M, Fujimoto Y, Matsumoto A, Ohtake T, Ono M, Kohgo Y.
Hepatocellular carcinoma associated with alcoholic liver disease: a
clinicopathological study and genetic polymorphism of aldehyde dehydrogenase 2.
Alcohol Clin Exp Res 20(9 Suppl):378A-382A., 1996
176. Poynard T, Bedossa P, Mathurin P, Ratziu V, Paradis V. Apolipoprotein A1 and
hepatic fibrosis. J Hepatol 22(2 Suppl):107-10, 1995
177. Paradis V, Laurent A, Mathurin P, et al.: Role of liver extracellular matrix in
transcriptional and post-transcriptional regulation of apolipoprotein A-I by
hepatocytes. Cell Mol Biol (Noisy-le-grand) 42(4):525-34, 1996
178. Poynard T, Lonjon I, Mathurin P, et al.: Prevalence of cholelithiasis according to
alcoholic liver disease: a possible role of apolipoproteins AI and AII. Alcohol Clin
Exp Res 19(1):75-80, 1995
179. Zimmermann A, Bachmann C, Baumgartner R. Severe liver fibrosis in
argininosuccinic aciduria. Arch Pathol Lab Med 110(2):136-40, 1986
180. Aiello VD, Reis MM, Benvenuti LA, Higuchi Mde L, Ramires JA, Halperin JA.
A possible role for complement in the pathogenesis of chronic chagasic
cardiomyopathy. J Pathol 197(2):224-9, 2002
181. Lu CT, Lan SJ, Hsieh CC, et al.: Prevalence and characteristics of areca nut
chewers among junior high school students in Changhua county, Taiwan.
Community Dent Oral Epidemiol 21(6):370-3., 1993
182. Jensen P, Johansen HK, Carmi P, Hoiby N, Cohen IR. Autoantibodies to
pancreatic hsp60 precede the development of glucose intolerance in patients with
cystic fibrosis. J Autoimmun 17(2):165-72, 2001
183. Fireman E, Shahar I, Shoval S, Messer G, Dvash S, Grief J. Morphological and
biochemical properties of alveolar fibroblasts in interstitial lung diseases. Lung
179(2):105-17, 2001
184. Cha YM, Dzeja PP, Shen WK, et al.: Failing atrial myocardium: energetic
55

deficits accompany structural remodeling and electrical instability. Am J Physiol
Heart Circ Physiol 284(4):H1313-20, 2003
185. Bresolin N, Moggio M, Bet L, et al.: Progressive cytochrome c oxidase
deficiency in a case of Kearns-Sayre syndrome: morphological, immunological,
and biochemical studies in muscle biopsies and autopsy tissues. Ann Neurol
21(6):564-72, 1987
186. Candeliere GA, Glorieux FH, Prud'homme J, St-Arnaud R. Increased expression
of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. N Engl J
Med 332(23):1546-51, 1995
187. Bloch DB, Bloch KD, Iannuzzi M, et al.: The gene for the alpha i1 subunit of
human guanine nucleotide binding protein maps near the cystic fibrosis locus. Am
J Hum Genet 42(6):884-8, 1988
188. Shapiro BL, Lam LF, Feigal RJ. Mitochondrial NADH dehydrogenase in cystic
fibrosis: enzyme kinetics in cultured fibroblasts. Am J Hum Genet 34(6):846-52,
1982
189. Pilewski JM, Engelhardt JF, Bavaria JE, Kaiser LR, Wilson JM, Albelda SM.
Adenovirus-mediated gene transfer to human bronchial submucosal glands using
xenografts. Am J Physiol 268(4 Pt 1):L657-65., 1995
190. Yoo JS, Moyer BD, Bannykh S, Yoo HM, Riordan JR, Balch WE.
Non-conventional trafficking of the cystic fibrosis transmembrane conductance
regulator through the early secretory pathway. J Biol Chem 277(13):11401-9,
2002
191. Lambert G, Becker B, Schreiber R, Boucherot A, Reth M, Kunzelmann K.
Control of cystic fibrosis transmembrane conductance regulator expression by
BAP31. J Biol Chem 276(23):20340-5, 2001
192. Gonzalez-Cuadrado S, Bustos C, Ruiz-Ortega M, et al.: Expression of leucocyte
chemoattractants by interstitial renal fibroblasts: up-regulation by drugs associated
with interstitial fibrosis. Clin Exp Immunol 106(3):518-22, 1996
193. Jimenez SA, Hitraya E, Varga J. Pathogenesis of scleroderma. Collagen. Rheum
Dis Clin North Am 22(4):647-74, 1996
194. Nejjari M, Couvelard A, Mosnier JF, et al.: Integrin up-regulation in chronic
liver disease: relationship with inflammation and fibrosis in chronic hepatitis C. J
Pathol 195(4):473-81, 2001
195. Yen TW, Aardal NP, Bronner MP, et al.: Myofibroblasts are responsible for the
desmoplastic reaction surrounding human pancreatic carcinomas. Surgery
131(2):129-34, 2002
196. Horiuchi T, Mason RJ, Kuroki Y, Cherniack RM. Surface and tissue forces,
surfactant protein A, and the phospholipid components of pulmonary surfactant in
56

leomycin-induced pulmonary fibrosis in the rat. Am Rev Respir Dis 141(4 Pt
1):1006-13, 1990
197. Valderrama R, Navarro S, Lopez JM, et al.: Synthesis and degradation of
collagen in pancreatic fibrogenesis. Pancreas 18(1):34-8, 1999
198. Davis KL, Laine GA, Geissler HJ, Mehlhorn U, Brennan M, Allen SJ. Effects of
myocardial edema on the development of myocardial interstitial fibrosis.
Microcirculation 7(4):269-80, 2000
199. Liu W, Smith DI, Rechtzigel KJ, Thibodeau SN, James CD. Denaturing high
performance liquid chromatography (DHPLC) used in the detection of germline
and somatic mutations. Nucleic Acids Res 26(6):1396-400, 1998
200. Jeoung DI, Bong Lee E, Lee S, et al.: Autoantibody to DNA binding protein B as
a novel serologic marker in systemic sclerosis. Biochem Biophys Res Commun
299(4):549-54, 2002
201. Kallenberg CG. Overlapping syndromes, undifferentiated connective tissue
disease, and other fibrosing conditions. Curr Opin Rheumatol 4(6):837-42, 1992
202. Chang YC, Tsai CH, Tai KW, Yang SH, Chou MY, Lii CK. Elevated vimentin
expression in buccal mucosal fibroblasts by arecoline in vitro as a possible
pathogenesis for oral submucous fibrosis. Oral Oncol 38(5):425-30, 2002
203. Chiang CP, Lang MJ, Liu BY, et al.: Expression of proliferating cell nuclear
antigen (PCNA) in oral submucous fibrosis, oral epithelial hyperkeratosis and oral
epithelial dysplasia in Taiwan. Oral Oncol 36(4):353-9., 2000
204. Torroni A, Stepien G, Hodge JA, Wallace DC. Neoplastic transformation is
associated with coordinate induction of nuclear and cytoplasmic oxidative
phosphorylation genes. J Biol Chem 265(33):20589-93., 1990
205. Hatalova I, Kolarov J. Synthesis and intracellular transport of cytochrome
oxidase subunit IV and ADP/ATP translocator protein in intact hepatoma cells.
Biochem Biophys Res Commun 110(1):132-9., 1983
206. Maruyama K, Takahashi H, Matsushita S, et al.: Genotypes of
alcohol-metabolizing enzymes in relation to alcoholic chronic pancreatitis in
Japan. Alcohol Clin Exp Res 23(4 Suppl):85S-91S., 1999
207. Trouve P, Legot S, Belikova I, et al.: Localization and quantitation of cardiac
annexins II, V, and VI in hypertensive guinea pigs. Am J Physiol 276(4 Pt
2):H1159-66., 1999
208. Della Gaspera B, Weinman S, Huber C, et al.: Overexpression of annexin V in
cystic fibrosis epithelial cells from fetal trachea. Exp Cell Res 219(2):379-83.,
1995
209. Santos MM, de Sousa M, Rademakers LH, Clevers H, Marx JJ, Schilham MW.
Iron overload and heart fibrosis in mice deficient for both beta2- microglobulin
57

and Rag1. Am J Pathol 157(6):1883-92., 2000
210. Anil S, Beena VT, Nair RG, Vijayakumar T. Evaluation of serum beta
2-microglobulin in premalignant and malignant lesions of the oral cavity. Oral
Surg Oral Med Oral Pathol Oral Radiol Endod 79(6):750-2., 1995
211. Colombi A, Wegmann W. Beta-2 microglobulin amyloidosis in a patient on
long-term continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int
9(4):321-4, 1989
212. Murao S, Collart FR, Huberman E. A protein containing the cystic fibrosis
antigen is an inhibitor of protein kinases. J Biol Chem 264(14):8356-60., 1989
213. Groma V. Demonstration of collagen type VI and alpha-smooth muscle actin in
renal fibrotic injury in man. Nephrol Dial Transplant 13(2):305-12., 1998
214. Reilly JT. Idiopathic myelofibrosis: pathogenesis, natural history and
management. Blood Rev 11(4):233-42., 1997
215. Demirci G, Nashan B, Pichlmayr R. Fibrosis in chronic rejection of human liver
allografts: expression patterns of transforming growth factor-TGFbeta1 and
TGF-beta3. Transplantation 62(12):1776-83., 1996
216. Ljubimov AV, Burgeson RE, Butkowski RJ, et al.: Extracellular matrix
alterations in human corneas with bullous keratopathy. Invest Ophthalmol Vis Sci
37(6):997-1007., 1996
217. Specks U, Nerlich A, Colby TV, Wiest I, Timpl R. Increased expression of type
VI collagen in lung fibrosis. Am J Respir Crit Care Med 151(6):1956-64., 1995
218. Takahara T, Sollberg S, Muona P, Uitto J. Type VI collagen gene expression in
experimental liver fibrosis: quantitation and spatial distribution of mRNAs, and
immunodetection of the protein. Liver 15(2):78-86., 1995
219. Aycock RS, Seyer JM. Collagens of normal and cirrhotic human liver. Connect
Tissue Res 23(1):19-31, 1989
220. Hasel C, Rau B, Perner S, Strater J, Moller P. Differential and mutually
exclusive expression of CD95 and CD95 ligand in epithelia of normal pancreas
and chronic pancreatitis. Lab Invest 81(3):317-26, 2001
221. Emoto Y, Kobayashi R, Akatsuka H, Hidaka H. Purification and characterization
of a new member of the S-100 protein family from human placenta. Biochem
Biophys Res Commun 182(3):1246-53, 1992
222. Corrales F, Gimenez A, Alvarez L, et al.: S-adenosylmethionine treatment
prevents carbon tetrachloride-induced S-adenosylmethionine synthetase
inactivation and attenuates liver injury. Hepatology 16(4):1022-7, 1992
223. Chen M, Zhang JT. Membrane insertion, processing, and topology of cystic
fibrosis transmembrane conductance regulator (CFTR) in microsomal membranes.
Mol Membr Biol 13(1):33-40, 1996
58

224. Ryan ST, Koteliansky VE, Gotwals PJ, Lindner V. Transforming growth
factor-beta-dependent events in vascular remodeling following arterial injury. J
Vasc Res 40(1):37-46, 2003
225. Menke A, Adler G. TGFbeta-induced fibrogenesis of the pancreas. Int J
Gastrointest Cancer 31(1-3):41-6, 2002
226. Mastruzzo C, Crimi N, Vancheri C. Role of oxidative stress in pulmonary
fibrosis. Monaldi Arch Chest Dis 57(3-4):173-6, 2002
227. Haralambie G. Vitamin B2 status in athletes and the influence of riboflavin
administration on neuromuscular irritability. Nutr Metab 20(1):1-8, 1976
228. Ikram H, Maslowski AH, Smith BL, Nicholls MG. The haemodynamic,
histopathological and hormonal features of alcoholic cardiac beriberi. Q J Med
50(200):359-75, 1981
229. Piano MR. Cellular and signaling mechanisms of cardiac hypertrophy. J
Cardiovasc Nurs 8(4):1-26, 1994
230. Tracy TF, Jr., Goerke ME, Bailey PV, Sotelo-Avila C, Weber TR. Growth-related
gene expression in early cholestatic liver injury. Surgery 114(3):532-7, 1993
231. Han DC, Isono M, Hoffman BB, Ziyadeh FN. High glucose stimulates
proliferation and collagen type I synthesis in renal cortical fibroblasts: mediation
by autocrine activation of TGF-beta. J Am Soc Nephrol 10(9):1891-9, 1999
59